J&P International Co.Ltd
⚠️ Moderate Risk
FEI: 3011539481 • Seoul • SOUTH KOREA
FEI Number
3011539481
Location
Seoul
Country
SOUTH KOREAAddress
292 #B05, 3f Garden5 Tool Munjeong2 Dong, , Seoul, , South Korea
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
Refusal History
Frequently Asked Questions
What is J&P International Co.Ltd's FDA import refusal history?
J&P International Co.Ltd (FEI: 3011539481) has 2 FDA import refusal record(s) in our database, spanning from 8/6/2015 to 8/6/2015.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. J&P International Co.Ltd's FEI number is 3011539481.
What types of violations has J&P International Co.Ltd received?
J&P International Co.Ltd has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about J&P International Co.Ltd come from?
All FDA import refusal data for J&P International Co.Ltd is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.